GoodRx Stock Upgraded on Growth Potential

GDRX has plenty of short covering potential

Laura McCandless

Deputy Editor

Apr 10, 2024 at 10:47 AM

GDRX

GoodRx Holdings Inc (NASDAQ:GDRX) stock is up 1.9% to trade at $6.87 this morning, after Keybanc upgraded the digital healthcare service to "overweight" from "sector weight," while setting a price target of $9. The analyst in coverage cited the potential for strong subscriber growth, as well as a positive shift in the company's monthly active users (MAUs).

GoodRx jumped nearly 4% premarket, but broad market headwinds are capping gains. The stock has support at its 80-day moving average, which has propped up the consolidation since an early-January bull gap. Year over year, the equity is up 17%.

There is still plenty of pessimism surrounding the stock. Factoring in today's bull note, 11 of the 20 analysts in coverage still carry a "hold" or worse rating on GDRX. Plus, short interest represents 12.5% of the stock's available float, and would take nearly six days to cover at the security's average pace of trading.

Follow @Schaeffers

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.